LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 47 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $109,000 | -82.4% | 300,000 | -67.2% | 0.00% | – |
| Q1 2022 | $621,000 | -83.2% | 913,576 | -42.9% | 0.00% | -100.0% |
| Q4 2021 | $3,693,000 | -49.6% | 1,598,695 | +0.0% | 0.00% | -66.7% |
| Q3 2021 | $7,322,000 | +3.2% | 1,598,644 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $7,098,000 | -39.0% | 1,598,644 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $11,638,000 | -4.6% | 1,598,644 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $12,198,000 | +91.9% | 1,598,644 | +128.4% | 0.01% | +66.7% |
| Q3 2020 | $6,356,000 | +1.0% | 700,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,293,000 | +82.0% | 700,000 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $3,458,000 | -31.4% | 700,000 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $5,040,000 | -33.4% | 700,000 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $7,567,000 | -16.8% | 700,000 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $9,100,000 | +31.6% | 700,000 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $6,916,000 | -5.0% | 700,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $7,280,000 | – | 700,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,466,783 | $5,758,000 | 0.09% |
| HARBOR CAPITAL ADVISORS, INC. | 226,731 | $154,000 | 0.07% |
| Sio Capital Management, LLC | 182,630 | $124,000 | 0.04% |
| Virtu Financial LLC | 71,475 | $49,000 | 0.00% |
| Independence Bank of Kentucky | 10,200 | $7,000 | 0.00% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $10,000 | 0.00% |
| Endurance Wealth Management, Inc. | 1,500 | $12,000 | 0.00% |
| Baker Brothers Advisors | 451,478 | $307,000 | 0.00% |
| Texas Yale Capital Corp. | 20,000 | $14,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 79,900 | $54,000 | 0.00% |